TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharma Nord Norge AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
37,276
|
40,155
|
32,797 |
Financial expenses |
27
|
33
|
32 |
Earnings before taxes |
1,087
|
1,211
|
1,027 |
Total assets |
19,307
|
21,018
|
16,692 |
Current assets |
17,413
|
19,068
|
14,776 |
Current liabilities |
17,986
|
19,522
|
14,930 |
Equity capital |
1,181
|
1,351
|
1,620 |
- share capital |
1,057
|
1,025
|
955 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
6.1%
|
6.4%
|
9.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
2.9%
|
3.0%
|
3.1% |
Return on assets (ROA) |
5.8%
|
5.9%
|
6.3% |
Current ratio |
96.8%
|
97.7%
|
99.0% |
Return on equity (ROE) |
92.0%
|
89.6%
|
63.4% |
Change turnover |
-4,123
|
4,924
|
8,316 |
Change turnover % |
-10%
|
14%
|
34% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.